{"id":"https://genegraph.clinicalgenome.org/r/31cb7944-8cfe-408f-b1b8-6fd3d9396d66v1.3","type":"EvidenceStrengthAssertion","dc:description":"Variants in *NAA15* were first reported in individuals with intellectual disability and autism by Stessman et al. in 2017 (PMID: 28191889), in a case cohort study of neurodevelopmental disorders in which 13 individuals with *NAA15* variants were described. Two additional case series have subsequently been published (PMIDs: 29656860, 31127942), with over 40 probands in total described in the literature. Affected individuals typically harbor *de novo* heterozygous truncating variants, although milder cases with missense variants and inheritance in families have been documented. Phenotypic features include variable levels of intellectual disability, motor and speech delay, and autism spectrum disorder.  Some individuals also present with dysmorphic features, cardiac abnormalities, and seizures.\n\n*NAA15* encodes the enzyme N-alpha-Acetyltransferase 15, a subunit of the NatA complex involved in co-translational acetylation of the peptide N-terminus. This gene-disease relationship is also supported by experimental evidence, including protein interaction with NAA10, involved in a neurodevelopmental disorder, and functional alterations in non-patient cells (PMIDs: 29656860, 33557580).\n\nIn summary, there is definitive evidence supporting the relationship between *NAA15* and autosomal dominant syndromic intellectual disability. This classification was approved by the Intellectual Disability and Autism Gene Curation Expert Panel on January 5, 2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/31cb7944-8cfe-408f-b1b8-6fd3d9396d66","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:classificationChange"},{"id":"cg:sopChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-11-03T18:22:18.495Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-01-05T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/545a9464-d07d-4d8e-b5d0-dc783380ced6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb94e650-848d-4ec6-a624-7af86d5fef99","type":"Finding","dc:description":"NAA15 and NAA10 interact to form human NatA (hNatA), one of six conserved metazoan N-terminal acetyltransferases. hNatA with associates with the intrinsically disordered Huntingtin Yeast two-hybrid Protein K (HYPK).\n\nNAA10 is implicated in NAA10-related syndrome which is characterized by substantial phenotypic variability, ranging from a severe lethal phenotype in males originally described as Ogden syndrome, to milder forms of intellectual disability in both males and females (PMID: 30054457). ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29754825","rdfs:label":"Protein Interaction (NatA complex)","demonstrates":{"id":"obo:MI_0208"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f13bd711-c969-40dd-8a24-a8c77dcfd22d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48312bf9-f714-41c5-b700-67979b9c9c91","type":"FunctionalAlteration","dc:description":"Ward et al. (2021) introduced NAA15 variants into human induced pluripotent stem cells (iPSCs) using CRISPR/Cas9 and assessed the consequences on RNA and protein expression. N-terminal acetylation levels of 32 and 9 NatA-specific targeted proteins were reduced in null and haploinsufficient NAA15 cells, respectively. In addition, steady-state protein levels of 562 proteins were altered in both null and haploinsufficient NAA15 cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33557580","rdfs:label":"Functional Alteration/Non-Patient Cells (iPSCs)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4da73234-a9c8-497d-938b-75aa1bb5aae2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5e04538-cab5-4555-8b90-01da1866312a","type":"FunctionalAlteration","dc:description":"NatA complex functionally replaces yeast NatA. NAA15 with patient variants failed to rescue the temperature-sensitive growth phenotype of yNatAÎ”. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","rdfs:label":"Functional Alteration/Non-Patient Cells (Yeast)"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/f9732e0c-1306-4fb5-b1b3-873258903e75_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c555b7f6-4da5-4890-8e01-ae13b9554495","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c555b7f6-4da5-4890-8e01-ae13b9554495_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","allele":{"id":"https://genegraph.clinicalgenome.org/r/794d0203-d511-4afc-b3d5-2871a5ea1f16","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.5(NAA15):c.913A>T (p.Lys305Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559847"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b53601fc-c684-4150-a19f-daaeaa9366ab","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b53601fc-c684-4150-a19f-daaeaa9366ab_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","allele":{"id":"https://genegraph.clinicalgenome.org/r/fb0effb5-89fe-4bb3-89ad-575843db2732","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.5(NAA15):c.163del (p.Thr55fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658823175"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/3ee4adbe-0ecb-404b-bb62-66114587a988","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ee4adbe-0ecb-404b-bb62-66114587a988_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28191889","allele":{"id":"https://genegraph.clinicalgenome.org/r/9d1556c8-3530-4850-b6d5-90c9ac2f5c54","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.5(NAA15):c.2086A>T (p.Lys696Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358270271"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/19a447fd-08b0-4b59-914f-5aff9d5950db","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/19a447fd-08b0-4b59-914f-5aff9d5950db_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","allele":{"id":"https://genegraph.clinicalgenome.org/r/0d7b81c6-7c39-468c-a07f-6d387868ff5c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.5(NAA15):c.420dup (p.Leu141ThrfsTer25)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320696"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cc2c7fdd-09b1-4dfb-a651-be22effac650","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc2c7fdd-09b1-4dfb-a651-be22effac650_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb6c78fc-7990-41aa-a73c-735663fd8841","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.5(NAA15):c.239_240del (p.His80fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/559844"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/09bd9994-572b-46cc-9390-d37aa9e029c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/09bd9994-572b-46cc-9390-d37aa9e029c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29656860","allele":{"id":"https://genegraph.clinicalgenome.org/r/2eab7842-0324-4cfb-b5da-9f1dfdb977ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_057175.4(NAA15):c.228_232del (p.Asp76Glufs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA555034937"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":5305,"specifiedBy":"GeneValidityCriteria8","strengthScore":13.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/M1AEmsuynYs","type":"GeneValidityProposition","disease":"obo:MONDO_0000508","gene":"hgnc:30782","modeOfInheritance":"obo:HP_0000006"},"version":"1.3","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f9732e0c-1306-4fb5-b1b3-873258903e75-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}